Group 1: Fudan Zhangjiang - Shareholders Yang Zongmeng and Wang Haibo plan to reduce their holdings by a total of up to 1.41% of the company's shares [1] - Yang Zongmeng intends to sell up to 10.36 million shares, representing 1.00% of the total share capital [1] - Wang Haibo plans to sell up to 4.27 million shares, representing 0.41% of the total share capital [1] Group 2: Aisen Co., Ltd. - Shareholders including Ailong Venture Capital and executives plan to reduce their holdings by a total of up to 3.86% of the company's shares [1] - Ailong Venture Capital intends to sell up to 2.644 million shares, representing 3.00% of the total share capital [1] - Other executives plan to sell smaller amounts, with individual reductions ranging from 0.17% to 0.45% of the total share capital [1] Group 3: Youyou Food - Actual controller Zhao Ying plans to reduce his holdings by up to 3% of the company's shares [3] - The planned reduction amounts to up to 12.83 million shares [3] Group 4: Chenfeng Technology - The company plans to sell idle assets, including 6 vehicles and 53 pieces of machinery, for a total estimated sale price of 8.1461 million yuan [5] - Expected disposal gains from the sale are approximately 3.6238 million yuan [5] Group 5: *ST Hengtai - The company will cancel its delisting risk warning and other risk warnings, with the stock name changing from "*ST Hengtai" to "Henglitai" [6] - The stock will be suspended for one day and the price fluctuation limit will change to 10% [6] Group 6: Xinyunda - Shareholder Wuku International Trust plans to reduce its holdings by up to 3% of the company's shares [9] - The planned reduction amounts to up to 5.9823 million shares [9] Group 7: Shaoyang Hydraulic - The company is planning a major asset restructuring, which involves issuing shares and cash to acquire part or all of Chongqing Xincheng Hangrui Technology Co., Ltd. [10] - The stock will be suspended for up to 10 trading days [10] Group 8: Xingwang Yuda - The company announced that part of its bank account funds, totaling 25.9335 million yuan, have been frozen [11] - The frozen amount represents 1.42% of the company's most recent audited net assets [11] Group 9: Tianrong Tianyu - Shareholder Yan Xuewei plans to reduce his holdings by up to 3% of the company's shares [12] - The planned reduction amounts to up to 4.2089 million shares [12] Group 10: Qiming Star - The chairman Wei Bing has resigned due to work adjustments at China Mobile Communications Group [13] Group 11: Aosaikang - The company's subsidiary has received a drug registration certificate for Methotrexate injection, which is considered equivalent to passing consistency evaluation [15][16] Group 12: Xinhau Optoelectronics - The company plans to transfer 100% equity of its wholly-owned subsidiary, Xinguang Energy Technology (Anhui) Co., Ltd. [17] Group 13: ST Baili - The company's controlling shareholder has been applied for bankruptcy liquidation due to inability to repay debts [19]

Group 1: Public Finance - The national general public budget revenue from January to May reached 96,623 billion yuan, a year-on-year decrease of 0.3% [2] - Tax revenue amounted to 79,156 billion yuan, down 1.6% year-on-year, while non-tax revenue increased by 6.2% to 17,467 billion yuan [2] - Central government budget revenue was 41,486 billion yuan, a decline of 3% year-on-year, while local government budget revenue increased by 1.9% to 55,137 billion yuan [2] Group 2: Securities Industry - The China Securities Regulatory Commission (CSRC) is seeking public opinion on the revised draft of the Securities Company Classification Evaluation Regulations, focusing on enhancing the evaluation framework and promoting high-quality development [3] - The new regulations aim to support differentiated development and specialized operations for small and medium-sized institutions [3] Group 3: Cross-Border Payment - The launch of the Cross-Border Payment System marks the realization of interconnectivity between the mainland and Hong Kong's rapid payment systems, allowing real-time cross-border remittances [4] - The first transaction under this system occurred in Shenzhen, enhancing the convenience of using the renminbi in cross-border retail scenarios [4] Group 4: Stock Market Regulations - The Shanghai Stock Exchange's new guidelines for designated trading will take effect, requiring brokers to process investor requests for unbinding from designated trading on the same day without delay [5] Group 5: Medical Device Industry - The National Medical Products Administration has approved measures to support the innovation of high-end medical devices, including optimizing special approval processes and enhancing post-market supervision [6] - Key products include medical robots, high-end imaging equipment, and AI medical devices, which are crucial for advancing new production capabilities in the medical device sector [6] Group 6: Corporate News - Shaoyang Hydraulic is planning a major asset restructuring and will be suspended from trading starting June 23 [8] - ST Hengtai will have its delisting risk warning removed starting June 24 [9] - Xinhau Optoelectronics plans to transfer 100% equity of its subsidiary Anhui Xinguang to Luxshare Precision [10] - A subsidiary of Aosaikang has received a drug registration certificate for methotrexate injection [11] - Shenzhen Huaqiang has made small equity investments in several semiconductor IDM or design companies through CVC [12] - Tianrong Tianyu's shareholder plans to reduce their stake by no more than 3% [13] - Xinxunda's shareholder intends to reduce their stake by no more than 3% [14] - Youyou Foods' actual controller plans to reduce their stake by no more than 3% [15] - Aisen Co., Ltd. shareholders plan to reduce their stake by no more than 3.86% [15] - ST Baili's controlling shareholder has been applied for bankruptcy liquidation [15] - StarNet Yuda has had part of its bank account funds frozen, involving an amount of 25.9335 million yuan [15] - Suoao Sensor has developed a brake pressure sensor applicable to AEBS [15] - Wanxing Technology has officially launched Wanxing Tianmu 2.0 in collaboration with Huawei [15] Group 7: Investment Opportunities - Galaxy Securities emphasizes the investment opportunities in the food and beverage industry driven by new categories and channels, predicting slow recovery in traditional food and beverage sectors [17] - CITIC Securities highlights the growth of domestic beauty brands in the high-end market, suggesting that local companies are well-positioned to capture market share in both high-end and mass markets [18]

Core Viewpoint - The company has received the drug registration certificate for Methotrexate Injection from the National Medical Products Administration, which is expected to enhance its competitiveness in the oncology market [1] Group 1: Drug Approval and Market Potential - The company's wholly-owned subsidiary, Jiangsu Aosaikang Pharmaceutical Co., Ltd., has recently obtained the drug registration certificate for Methotrexate Injection [1] - The active pharmaceutical ingredient for Methotrexate Injection received a marketing application approval notice in May 2025 [1] - Methotrexate Injection can be used alone to treat breast cancer and gestational trophoblastic neoplasia, or in combination with other chemotherapy drugs for osteosarcoma and acute leukemia [1] Group 2: Sales Performance and Future Impact - According to the PDB database, the average annual sales of Methotrexate Injection in sample hospitals over the past five years is approximately 140 million yuan [1] - The market outlook for Methotrexate Injection is broad, indicating significant sales potential [1] - The acquisition of the drug registration certificate will enrich the company's oncology product portfolio and positively impact the company's future operations [1]